Sun Life: Q3 Earnings Snapshot

Sun Life Financial (SLF) reported 10% growth in Q3 underlying EPS and raised its dividend, despite market-related losses and acquisition costs. Underlying net income rose 9% to CAD 1.146B, while reported net income fell to CAD 785M. The company cited higher interest rates and acquisition costs for the gap between underlying and reported results. SLF's CFO and president discussed segment performance, including U.S. stop-loss growth, disability claims pressure, and asset management outflows.

Sun Life Financial (SLF) received Buy ratings from BMO Capital and Scotiabank, with a C$118.00 price target from BMO. TD Cowen downgraded it to Hold. Q2 revenue was C$13.93B, net profit C$1.08B, up from C$9.2B and C$778M last year.

Sun Life Financial reported Q3 2026 net income of $785M, down from $1.1B a year ago, citing market impacts and acquisition costs. MFS saw $26.9B in outflows, while US employee benefits faced higher long-term disability claims. US medical stop-loss earnings rose 45% YoY, and Asia new business CSM declined due to competition. The company expects to reach a 35%+ FRE margin for GreenOak and is confident in its 20% ROE target.

Sun Life (SLF) reported Q3 2026 earnings, highlighting 6% growth in Canada and 8% in Asia. Insurance sales rose 12%, wealth sales in Canada up 21%. GreenOak saw $4B in net flows. The company launched new initiatives, partnerships, and AI tools to drive growth. Underlying EPS grew 10%, ROE at 19%, and dividend increased to $1 per share.

Sun Life Financial (SLF) fell 10% after reporting US$26.9B net outflows at MFS, its US fund manager. Underlying EPS rose 10% to C$2.05, but reported profit dropped 29% due to interest rates and deal costs. Two brokers downgraded the stock, citing MFS outflows and industry-wide trends. CEO Kevin Strain attributed outflows to a preference for passive strategies. T. Rowe Price (TROW) and Unum Group (UNM) also reported similar industry challenges.

Sun Life Financial (SLF) stock fell 10.6% to $102.36 after reporting Q3 results. Underlying EPS beat estimates at $2.05, but net income dropped 29% to $785M due to U.S. disability claims losses. Analysts downgraded the stock, citing U.S. growth uncertainty. The broader market decline also contributed to the drop.